Fourth Circuit Rejects Generic Drug Maker’s Challenge to West Virginia’s Medication Abortion Ban
- July 18, 2025
The Fourth Circuit held that the federal regulatory regime for the abortion pill mifepristone do not preempt West Virginia’s near-total ban on abortions to the extent it applies to those induced via medication.
ARTICLE TAGS
You must be logged in to access this content.